Newsletter AHDS\/ MCT8 Deficiency – 4th Addition<\/a><\/p>\n\n\n\n Triiodothyroacetic acid treatment in MCT8 deficiency: a word of nuance<\/a><\/p>\n\n\n\n Pharmacological and BBB-targeted genetic therapies for thyroid hormonedependent hypomyelination<\/a><\/p>\n\n\n\n AAV9-based delivery of MCT8 to Mct8 deficient mouse brain<\/a><\/p>\n\n\n\n Pushing Forward: Remyelination as the new frontier in CNS diseases<\/a><\/p>\n\n\n\n Further Insights into the Allan-Herndon- Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation<\/a><\/p>\n\n\n\n High T3, low T4 serum levels in Mct8\u2010deficiency are not caused by increased hepatic conversion through type I\u2010deiodinase<\/a><\/p>\n\n\n\n Redefining the Pediatric Phenotype of X-Linked Monocarboxylate Transporter 8 (MCT8) Deficiency: Implications for Diagnosis and Therapies<\/a><\/p>\n\n\n\n Efficient activation of pathogenic \u0002Phe501 mutation in monocarboxylate transporter 8 by chemical and pharmacological chaperones<\/a><\/p>\n\n\n\n Thyroid hormone transporters\u2014functions and clinical implications<\/a><\/p>\n\n\n\n MCT8 expression in human fetal cerebral cortex is reduced in severe intrauterine growth restriction<\/a><\/p>\n\n\n\n Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis<\/a><\/p>\n\n\n\n Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis<\/a><\/p>\n\n\n\n Altered Behavioral Performance and Live Imaging of Circuit-Specific Neural Deficiencies in a Zebrafish Model for Psychomotor Retardation<\/a><\/p>\n\n\n\n Clinical Course and Images of Four Familial Cases of Allan-Herndon-Dudley Syndrome With a Novel Monocarboxylate Transporter 8 Gene Mutation<\/a><\/p>\n\n\n\n Structure and Function of Thyroid Hormone Plasma Membrane Transporters<\/a><\/p>\n\n\n\n In Vitro and Mouse Studies Supporting Therapeutic Utility of Triiodothyroacetic Acid in MCT8 Deficiency<\/a><\/p>\n\n\n\n Hypotonic male infant and MCT8 deficiency – a diagnosis to think about<\/a><\/p>\n\n\n\n Placenta passage of the thyroid hormone analogue DITPA to male wild-type and Mct8 deficient mice<\/a><\/p>\n\n\n\n Cerebral Cortex Hyperthyroidism of Newborn Mct8- Deficient Mice Transiently Suppressed by Lat2 Inactivation<\/a><\/p>\n\n\n\n MCT 8 in human fetal cerebral cortex is reduced in severe intrauterine growth restriction<\/a><\/p>\n\n\n\n Mutations in MCT8 in Patients with Allan-Herndon- Dudley-Syndrome Affecting Its Cellular Distribution<\/a><\/p>\n\n\n\n AHDS in two consecutive generations<\/a><\/p>\n\n\n\n Tetrac Can Replace Thyroid Hormone During Brain Development in Mouse Mutants Deficient in the Thyroid Hormone Transporter Mct8<\/a><\/p>\n\n\n\n Zebrafish as a model to study peripheral thyroid hormone metabolism in vertebrate development<\/a><\/p>\n\n\n\n Changes in Thyroid Status During Perinatal Development of MCT8-Deficient Male Mice<\/a><\/p>\n\n\n\n Mct8-Deficient Mice Have Increased Energy Expenditure and Reduced Fat Mass That Is Abrogated by Normalization of Serum T3 Levels<\/a><\/p>\n\n\n\n MCT8 Deficiency: Extrapyramidal Symptoms and Delayed Myelination as Prominent Features<\/a><\/p>\n\n\n\n A child with a deletion in the monocarboxylate transporter 8 gene: 7-year follow-up and effects of thyroid hormone treatment<\/a><\/p>\n\n\n\n Finding the Way into the Brain without MCT8<\/a><\/p>\n\n\n\n Diiodothyropropionic Acid (DITPA) in the Treatment of MCT8 Deficiency<\/a><\/p>\n\n\n\n Zebrafish as a model for monocarboxyl transporter 8-deficiency<\/a><\/p>\n\n\n\n Tissue-specific effects of mutations in the thyroid hormone transporter MCT8<\/a><\/p>\n\n\n\n Lack of Action of Exogenously Administered T3 on the Fetal Rat Brain Despite Expression of the Monocarboxylate Transporter 8<\/a><\/p>\n\n\n\n Retinoic Acid Induces Expression of the Thyroid Hormone Transporter, Monocarboxylate Transporter 8 (Mct8)<\/a><\/p>\n\n\n\n Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8<\/a><\/p>\n\n\n\n Thyroid hormone action during brain development: More questions than answers<\/a><\/p>\n\n\n\n Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion<\/a><\/p>\n\n\n\n Characterization of thyroid hormone transporter expression during tissue-specific metamorphic events in Xenopus tropicalis<\/a><\/p>\n\n\n\n The tricyclic antidepressant desipramine inhibits T3 import into primary neurons<\/a><\/p>\n\n\n\n Thyroid hormone analog 3,5-diiodothyropropionic acid promotes healthy vasculature in the adult myocardium independent of thyroid effects on cardiac function<\/a><\/p>\n\n\n\n A Thyroid Hormone Analog with Reduced Dependence on the Monocarboxylate Transporter 8 for Tissue Transport<\/a><\/p>\n\n\n\n A novel role for MCT8: Control of thyroid hormone secretion<\/a><\/p>\n\n\n\n Axon\u2013Myelin Interactions during a Viral Infection of the Central Nervous System<\/a><\/p>\n\n\n\n Pelizaeus\u2013Merzbacher\u2013Like Disease Presentation of MCT8 Mutated Male Subjects<\/a><\/p>\n\n\n\n Beneficial Effects of Propylthiouracil plus L-Thyroxine Treatment in a Patient with a Mutation in MCT8<\/a><\/p>\n\n\n\n Thyroid hormone transport in and out of cells<\/a><\/p>\n\n\n\n Novel Pathogenic Mechanism Suggested by Ex Vivo Analysis of MCT8 (SLC16A2) Mutations<\/a><\/p>\n\n\n\n2016<\/h3>\n\n\n\n
2015<\/h3>\n\n\n\n
2014<\/h3>\n\n\n\n
2013<\/h3>\n\n\n\n
2012<\/h3>\n\n\n\n
2011<\/h3>\n\n\n\n
2010<\/h3>\n\n\n\n
2009<\/h3>\n\n\n\n
2008<\/h3>\n\n\n\n